Group 1 - The core viewpoint is that the Sci-Tech Innovation Board (STAR Market) is evolving into an international market with a strong international gene and a friendly investment ecosystem for global investors [1][2] Group 2 - The operating activities of companies listed on the STAR Market are increasingly internationalized, with China's biopharmaceutical sector's business development (BD) transactions accounting for 38% of the global total in 2023 [1] - Foreign investment participation in the STAR Market is rising, facilitated by channels such as QFII, RQFII, and the Shanghai-Hong Kong Stock Connect, with over 3 trillion yuan in products tracking 33 STAR Market indices [1] - STAR Market companies prioritize communication with international investors, holding 3,425 performance briefings and conducting international roadshows, including bilingual presentations to enhance understanding of China's innovation value [2]
上交所副总经理傅浩：科创板有很强的国际基因 正发展成一个国际化的市场
Sou Hu Cai Jing·2025-11-13 05:42